How to Test for Herpes: Swab, Blood & At-Home Options

Testing for herpes comes down to two main approaches: a swab taken directly from a sore, or a blood test that looks for antibodies your immune system has made against the virus. Each method answers a different question and works best in different situations. A swab tells you whether an active lesion is caused by herpes right now, while a blood test tells you whether you’ve been infected at some point in the past. Both can distinguish between HSV-1 and HSV-2, but they differ sharply in accuracy, timing, and what they can actually reveal. At-home kits have entered the picture too, though they come with their own trade-offs worth understanding before you order one.

Swab Testing Is the Gold Standard for Active Sores

If you have a visible blister, sore, or ulcer, a swab test is the most reliable way to confirm herpes. A clinician collects fluid or cells directly from the lesion and sends it to a lab, where it’s analyzed using PCR (a method that detects the virus’s genetic material). PCR swabs are far more sensitive than the older technique of viral culture, where the sample was placed in a dish to see if the virus would grow. In one study comparing methods on mucosal swab samples from nearly 300 people with known HSV infection, PCR detected herpes DNA in about 12% of all samples, while culture only grew the virus from 3%, meaning PCR caught roughly four times as many positive results.

That gap matters because herpes lesions shed virus unevenly. Culture requires a relatively high amount of live virus to produce a result, which is why it misses infections that PCR picks up. A head-to-head comparison of different swab methods found that PCR-based assays detected nearly all true positives, while culture and older antibody-staining techniques each missed more than 10% of confirmed cases.

The practical takeaway: if your provider offers a swab, PCR is what you want. Some clinics still use viral culture, and while a positive culture result is reliable, a negative one doesn’t rule herpes out. If your swab comes back negative but you’re still suspicious, PCR or a follow-up blood test can fill in the picture.

Timing Matters Enormously for Swabs

Swab tests work best when a lesion is fresh. In a classic study tracking recurrent cold sores, virus levels in lesion swabs peaked within the first 24 hours, and the proportion of swabs that tested positive was highest at that point as well, reaching about 89%.

As a sore begins to crust over and heal, the amount of detectable virus drops quickly. By the time a lesion is dry and scabbed, a swab may easily come back negative even though herpes caused the sore. This is why clinicians stress getting swabbed as soon as possible. If you notice a new sore, don’t wait for your next scheduled appointment if you can avoid it. Urgent care or walk-in sexual health clinics can perform a swab the same day. Waiting even two or three days can mean the difference between a clear diagnosis and an inconclusive result.

How Blood Tests Work and Where They Fall Short

Blood tests for herpes don’t detect the virus itself. Instead, they look for IgG antibodies, proteins your immune system produces in response to HSV infection. Because antibodies take time to develop, blood tests can’t catch a brand-new infection. Most people develop detectable IgG levels within a few weeks, but it can take up to 12 weeks or occasionally longer for antibodies to reach levels the test can pick up. That delay is the “window period,” and it’s the main reason a blood test right after a possible exposure can give a falsely reassuring negative result.

Even after the window period, blood test accuracy varies depending on the virus type and the specific test used. A study evaluating several widely used automated antibody platforms found that for HSV-2, sensitivity and specificity were generally strong, both above 97% on the better-performing assays. HSV-1 antibody testing was notably weaker, with sensitivity below 85% on some platforms and one assay showing specificity as low as about 89%.

⁴

A separate study comparing immunoblot, ELISA, and chemiluminescent assays reported high overall accuracy for both HSV-1 and HSV-2 when immunoblot was used as the reference, with sensitivity and specificity figures above 94% across all three methods.

⁵

The problem is that even a small rate of false positives becomes a big deal in populations where herpes is less common. If only a small fraction of people being tested actually have HSV-2, a test with 97% specificity will still flag some uninfected people as positive. This is part of why the U.S. Preventive Services Task Force recommends against routine serologic screening for genital herpes in asymptomatic people, citing the most widely used FDA-approved screening test’s low specificity and high false-positive rate in a general-population setting.

⁶

A study in Kenya illustrated this dramatically: using Western blot as the reference standard, the HerpeSelect ELISA had 100% sensitivity but only 40% specificity for HSV-2, meaning it correctly identified every true positive but incorrectly flagged a large number of uninfected people.

⁷

When Antibody Results Land in the Gray Zone

One frustrating feature of herpes blood tests is the “low positive” result. Most ELISA-based assays report an index value. Values above a certain cutoff are called positive, below it negative, and there’s a range in between (often roughly 1.1 to 3.5 for HSV-2 on the HerpeSelect) that’s considered equivocal or low positive. A significant portion of results in this low-positive range turn out to be false positives when checked against a more definitive test. A study comparing recurrent genital herpes cases found that the combined accuracy of HSV-1 and HSV-2 antibody positivity together was only about 35% when PCR was used as the reference standard, underscoring how poorly serology can perform in certain clinical scenarios.

⁸

If you get a low-positive result, most experts recommend confirmatory testing. The gold standard confirmatory test is the Western blot, developed at the University of Washington. It’s highly accurate but not available at most commercial labs. Your clinician typically has to order it through a specialized reference laboratory. The Biokit rapid test and inhibition assays are other options sometimes used to confirm ambiguous results. Don’t treat a single low-positive ELISA as a definitive diagnosis.

Why Herpes Isn’t on a Standard STI Panel

One of the most common misconceptions is that herpes is included when you ask your doctor for “a full STI screening.” In most settings, it isn’t. Standard panels typically cover chlamydia, gonorrhea, syphilis, and HIV. Herpes serology is left off deliberately, not because doctors don’t take it seriously, but because the USPSTF found that screening asymptomatic people with the available blood tests produces too many false positives and hasn’t been shown to reduce transmission.

⁶

This doesn’t mean you can’t request a herpes blood test. You absolutely can. But you’ll usually need to ask for it specifically, and a good clinician will walk you through what the results can and can’t tell you before ordering it. If you have symptoms, a swab is the first-line test your doctor should offer. Blood testing makes the most sense when you want to know your status but don’t have an active outbreak to swab, when a partner has been diagnosed with herpes and you want to know if you carry it too, or when you’re pregnant and your partner has a history of genital herpes.

At-Home Testing Kits

Several companies now sell at-home herpes test kits online. These typically fall into two categories. The first is a finger-prick blood collection kit that you mail to a lab for IgG antibody analysis. The second is a kit affiliated with a telehealth visit, where a provider reviews your results and may offer counseling or treatment. In both cases, the underlying lab test is usually the same ELISA-based antibody assay used in clinics.

That means at-home blood kits inherit all the same limitations of in-clinic blood testing: the 12-week window period, the possibility of false positives (especially low-positive results), the inability to tell you where on your body the infection is, and weaker performance for HSV-1 than for HSV-2. What at-home kits don’t offer is a swab test. If you have an active sore, an at-home blood kit is the wrong tool. You need to be seen in person so that the lesion can be swabbed while it’s fresh.

The main advantage of at-home kits is convenience and privacy, both of which are real concerns for a lot of people. The main disadvantage, beyond the accuracy caveats, is that you may get a result you don’t know how to interpret without clinical support. A telehealth-affiliated kit at least pairs the result with a brief consultation. A standalone mail-order kit may leave you staring at an index value with no guidance. If you go this route, look for a service that includes a follow-up with a healthcare provider, and be aware that a positive result on an at-home kit should be confirmed before making major decisions about your health or relationships.

Knowing the Type Matters More Than You’d Think

HSV-1 and HSV-2 behave quite differently, particularly when it comes to genital infections. Historically, HSV-1 was associated with oral cold sores and HSV-2 with genital herpes, but that division has blurred. HSV-1 now causes a substantial share of new genital herpes cases, especially among younger adults. What hasn’t changed is that the two types have different patterns of recurrence and shedding once they establish genital infection.

A study following people with first-episode genital HSV-1 found that shedding was detected on about 12% of days at two months after the first episode but declined to about 7% of days by 11 months. Among those with a true primary infection (meaning no pre-existing HSV antibodies), roughly 71% had at least one recurrence in the first year, though the median was just one recurrence. People with nonprimary infections had significantly fewer recurrences and lower shedding rates.

⁹

By contrast, genital HSV-2 tends to recur more frequently and shed more persistently over time. This difference has real implications for treatment decisions, transmission risk counseling, and how worried you need to be going forward. A test result that just says “herpes positive” without specifying the type is incomplete. Whether you’re getting a swab or a blood test, make sure the order includes type-specific testing so you and your provider can have a meaningful conversation about what to expect.

Asymptomatic Shedding and the Case for Testing Without Symptoms

Most herpes transmission happens when the infected person has no visible sores, a phenomenon called asymptomatic or subclinical shedding. In a landmark study, researchers found that among people who were HSV-2 seropositive but reported no history of genital herpes, about 72% shed virus from the genital area at some point during the study period. The rate of subclinical shedding in this group was similar to that in people who did have a known history of outbreaks.

¹⁰

A larger study confirmed this pattern: subclinical shedding rates were higher in people with symptomatic infection compared to those with asymptomatic infection (about 13% of days versus about 9% of days), but the amount of virus detected during subclinical episodes was essentially the same in both groups.

¹¹

This is the strongest argument for testing even when you feel fine. If you don’t know you carry HSV-2, you can’t take steps to reduce transmission, whether that means discussing it with a partner, using antivirals, or being alert for subtle symptoms you might have previously dismissed as irritation or an ingrown hair.

How Antiviral Medication Affects Test Results

If you’re already taking daily antiviral medication like acyclovir or valacyclovir, it won’t interfere with a blood test. Antibodies stick around regardless of whether you’re suppressing the virus. Blood testing works the same on or off medication.

Swab tests are a different story. Suppressive antiviral therapy dramatically reduces the amount of virus at mucosal surfaces. In a crossover trial, shedding was detected on about 18% of days when participants took no medication, but dropped to roughly 1% of days on standard-dose acyclovir. Even standard-dose valacyclovir reduced shedding to under 6% of days, and high-dose valacyclovir brought it lower still, to about 3%.

¹²

The implication for testing: if you’re on daily antivirals and a lesion appears, a swab is still worth attempting, but the chance of a false negative is meaningfully higher because the medication is reducing viral load at the surface. If the swab comes back negative and herpes is still suspected, a blood test can help clarify things, since it measures your immune response rather than live virus.

Testing During Pregnancy

Herpes testing takes on added urgency during pregnancy because a first-episode genital herpes outbreak near the time of delivery poses a serious risk of neonatal herpes, a rare but potentially devastating condition. For pregnant women who develop genital lesions and don’t have a known herpes history, French obstetric guidelines recommend virological confirmation by PCR swab along with type-specific IgG blood testing.

¹³

The combination of swab and blood test in this context is informative: if the swab is positive but the blood test shows no pre-existing antibodies, that suggests a true primary infection acquired during or just before pregnancy, which carries the highest risk of transmission to the baby during delivery. If antibodies are already present, the infection is likely a recurrence, and the risk to the newborn is much lower.

A cost-effectiveness analysis estimated that offering type-specific HSV-2 serology to 100,000 pregnant women and providing antiviral suppressive therapy to those who tested positive would prevent roughly 16 cases of neonatal herpes and nearly 200 cesarean deliveries, at a cost considered within conventional thresholds for acceptable healthcare spending.

¹⁴

PCR swabs in neonates themselves are also highly valuable. A comparison of PCR versus culture for surface swabs from newborns found PCR had 100% sensitivity and 100% specificity, while culture missed half of the positive cases.

¹⁵

What Testing Costs

The price of herpes testing varies widely depending on where you live, whether you have insurance, and which test is ordered. A systematic review of healthcare costs associated with herpes diagnosis found that screening costs ranged from about $7 to $100 per test, while episodic treatment ranged from under a dollar to $35 and annual suppressive therapy ranged from $240 to $2,580.

¹⁶

In the United States, if you have insurance, a herpes blood test ordered by your doctor is often covered, though you may face a copay. STI clinics funded by public health departments sometimes offer testing on a sliding-fee scale. At-home test kits typically run $50 to $150 out of pocket and are rarely covered by insurance. If you need the Western blot for confirmation, expect to pay a few hundred dollars out of pocket, since many insurance plans don’t cover it.

The Emotional Side of Getting Tested

Fear of the emotional fallout is one of the most common reasons people avoid herpes testing. That fear deserves to be taken seriously, but the research paints a more reassuring picture than many expect. A systematic review of nine studies on the psychosocial effects of HSV-2 serological testing found that seven reported no persistent negative impact on participants’ mental health or sexual satisfaction. Two studies noted some negative effects: one small study found increased distress in HSV-2-positive college students at three months, and another found self-reported feelings of sexual undesirability up to a year after diagnosis in some individuals. Interestingly, the perceived severity of a herpes diagnosis was rated as moderately severe before testing, but participants who tested positive actually rated it as less severe afterward.

¹⁷

Another study looking specifically at asymptomatic people who received a positive HSV-2 diagnosis found no significant lasting psychological differences compared to those who tested negative, though many individuals did report a notable short-term impact on quality of life. The people most affected tended to be those who were already interpersonally vulnerable before the diagnosis, with higher baseline interpersonal sensitivity and lower social support predicting worse adjustment.

¹⁸

If you’re anxious about testing, it’s worth knowing that the anticipation tends to be worse than the reality. Pre-test counseling, where a provider explains what the results mean and don’t mean, can make a real difference. If you’re someone who already struggles with anxiety or feelings of social isolation, letting your clinician know before getting tested is a reasonable step so they can connect you with appropriate support.